NCJ Number
253011
Date Published
October 2018
Length
8 pages
Annotation
Information and data are provided for the Missouri prescription drug monitoring program, named the Saint Louis County Prescription Drug Monitoring Program (SLCPDMP), which is administered by the St. Louis County Department of Public Health.
Abstract
The email address is provided for the SLCPDMP, along with website addresses for its following functions: general information, enrollment, data queries, data upload, and statistics. Contact information is provided for the Assessment, Evaluation, and Policy Manager, and the SLCPDMP Coordinator. Data for 2017 cover the state population (6,135,888), DEA registered prescribers (25,512), and DEA registered dispensers (1,405). SLCPDMP available reports are listed. SLCPDMP funding for 2018 was provided by a Harold Rogers grant and "other funding." SLCPDMP staff numbers for 2018 are provided for the following job categories: operational (0.83), technical (0.33), analytical (0.83), and "other" (0). Key dates for the SLCPDMP pertain to the enabling legislation (March 2016), becoming operational (April 2017), initial user access (April 2017), on-line access (April 2017), and electronic reporting (April 2017). Access information is provided for statutes and rules relevant to SLCPDMP's policies and procedures. Daily reporting is required for prescribers, including veterinarians, on controlled substances in schedules II, III, and IV. Hospitals, law enforcement agencies, and emergency medical services must provide information on the administering of naloxone. Required reporters also include anyone who is a witness to or participant in naloxone administration. Miscellaneous capabilities and policies of the SLCPDMP are listed. This report does not indicate any required enrollment in or use of the SLCPDMP. Law enforcement agencies' access to SLCPDMP data requires a subpoena and court approval, and the request must be submitted on-line. No requirements are reported for data retention. Training in the use of SLCPDMP is available for prescribers and dispensers, but is not required. Technological capabilities and requestor report production for SLCPDMP are indicated.